Investigation of the Component of Propionibacterium Acnes (Corynebacterium Parvum) Responsible for Macrophage Activation

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 1980 Feb 1

PMID 7380542

Citations 1

Authors

G E Buck

M T Kelly

Affiliations

Soon will be listed here.

Abstract

Mouse peritoneal macrophages, activated with Propionibacterium acnes (Corynebacterium parvum) in vivo, exhibited altered morphological characteristics, increased acid phosphatase activity, and release of [EH]thymidine-labeled DNA from tumor cells in vitro. Comparison with macrophages from mice injected with a control organism, P. jensenii, showed that the morphological changes, but not acid phosphatase, correlated with the development of tumoricidal activity. Investigation of the microbial component responsible for this activity indicated it was heat stable and refractory to extraction by methanol-chloroform, dilute acid, butanol, or a serial combination of extraction procedures. When the cells were disrupted by mechanical breakage, no activity could be found in the cell wall, soluble cytoplasm, or particulate cytoplasm. These results suggest that intact organisms are required for macrophage activation, and they may resolve conflicting reports on the nature of the immunostimulating activity of P. acnes.

Citing Articles

The Role of in Sarcoidosis: From Antigen to Treatable Trait?.

Kraaijvanger R, Veltkamp M Microorganisms. 2022; 10(8).

PMID: 36014067 PMC: 9415339. DOI: 10.3390/microorganisms10081649.

References

PREVOT A, THOUVENOT H . [Influence of the cell wall of Corynebacterium parvum (strain 936 B) on the reticuloendothelial system of mice]. C R Acad Hebd Seances Acad Sci D. 1968; 267(12):1061-2. View

Adlam C, Broughton E, Scott M . Enhanced resistance of mice to infection with bacteria following pre-treatment with Corynebacterium parvum. Nat New Biol. 1972; 235(59):219-20. DOI: 10.1038/newbio235219a0. View

Scott M . Biological effects of the adjuvant Corynebacterium parvum. I. Inhibition of PHA, mixed lymphocyte and GVH reactivity. Cell Immunol. 1972; 5(3):459-68. DOI: 10.1016/0008-8749(72)90072-x. View

Howard J, Christie G, Scott M . Biological effects of Corynebacterium parvum. IV. Adjuvant and inhibitory activities on B lymphocytes. Cell Immunol. 1973; 7(2):290-301. DOI: 10.1016/0008-8749(73)90251-7. View

ONEILL G, Henderson D, White R . The role of anaerobic coryneforms on specific and non-specific immunological reactions. I. Effect on particle clearance and humoral and cell-mediated immunological responses. Immunology. 1973; 24(6):977-95. PMC: 1422929. View

Adlam C, Scott M . Lympho-reticular stimulatory properties of Corynebacterium parvum and related bacteria. J Med Microbiol. 1973; 6(3):261-74. DOI: 10.1099/00222615-6-3-261. View

FAUVE R, Hevin B . Immunostimulation with bacterial phospholipid extracts. Proc Natl Acad Sci U S A. 1974; 71(2):573-7. PMC: 388050. DOI: 10.1073/pnas.71.2.573. View

Collins F, Scott M . Effect of Corynebacterium parvum treatment on the growth of Salmonella enteritidis in mice. Infect Immun. 1974; 9(5):863-9. PMC: 414899. DOI: 10.1128/iai.9.5.863-869.1974. View

Ghaffar A, Cullen R, Dunbar N, Woodruff M . Anti-tumour effect in vitro of lymphocytes and macrophages from mice treated with Corynebacterium parvum. Br J Cancer. 1974; 29(3):199-205. PMC: 2009103. DOI: 10.1038/bjc.1974.59. View

10.

Olivotto M, Bomford R . In vitro inhibition of tumour cell growth and DNA synthesis by peritoneal and lung macrophages from mice injected with Corynebacterium parvum. Int J Cancer. 1974; 13(4):478-88. DOI: 10.1002/ijc.2910130406. View

11.

Castro J . The effect of Corynebacterium parvum on the structure and function of the lymphoid system in mice. Eur J Cancer (1965). 1974; 10(2):115-20. DOI: 10.1016/0014-2964(74)90062-0. View

12.

Scott M . Depression of delayed-type hypersensitivity by Corynebacterium parvum: mandatory role of the spleen. Cell Immunol. 1974; 13(2):251-63. DOI: 10.1016/0008-8749(74)90243-3. View

13.

Korontzis M, Jolles P . Hydrosoluble immunopotentiating substances extraced from Corynebacterium parvum. Immunol Commun. 1974; 3(6):593-603. DOI: 10.3109/08820137409061137. View

14.

Morrison D, Leive L . Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures. J Biol Chem. 1975; 250(8):2911-19. View

15.

Bomford R, Christie G . Mechanisms of macrophage activation by corynebacterium parvum. II. In vivo experiments. Cell Immunol. 1975; 17(1):150-5. DOI: 10.1016/s0008-8749(75)80015-3. View

16.

Basic I, Milas L, Grdina D, Withers H . In vitro destruction of tumor cells by macrophages from mice treated with Corynebacterium granulosum. J Natl Cancer Inst. 1975; 55(3):589-96. DOI: 10.1093/jnci/55.3.589. View

17.

Kirchner H, HOLDEN H, Herberman . Splenic suppressor macrophages induced in mice by injection of Corynebacterium parvum. J Immunol. 1975; 115(5):1212-6. View

18.

McBride W, Dawes J, Tuach S . Antitumor activity of Corynebacterium parvum extracts. J Natl Cancer Inst. 1976; 56(2):437-9. View

19.

Oettgen H, Pinsky C, DELMONTE L . Treatment of cancer with immunomodulators. Med Clin North Am. 1976; 60(3):511-37. DOI: 10.1016/s0025-7125(16)31895-8. View

20.

Fisher B, Wolmark N . Correlation of antitumor chemoimmunotherapy with bone marrow macrophage precursor cell stimulation and macrophage cytotoxicity. Cancer Res. 1976; 36(7 PT 1):2241-7. View